enVVeno Medical (NVNO) Current Deferred Revenue (2018 - 2020)

Historic Current Deferred Revenue for enVVeno Medical (NVNO) over the last 3 years, with Q3 2020 value amounting to $33000.0.

  • enVVeno Medical's Current Deferred Revenue changed 0.0% to $33000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $33000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $33000.0 for FY2019, which is 0.0% changed from last year.
  • enVVeno Medical's Current Deferred Revenue amounted to $33000.0 in Q3 2020, which was down 0.0% from $33000.0 recorded in Q1 2020.
  • enVVeno Medical's 5-year Current Deferred Revenue high stood at $49000.0 for Q2 2018, and its period low was $33000.0 during Q4 2018.
  • Its 3-year average for Current Deferred Revenue is $35044.4, with a median of $33000.0 in 2018.
  • The largest annual percentage gain for enVVeno Medical's Current Deferred Revenue in the last 5 years was 0.0% (2019), contrasted with its biggest fall of 3265.31% (2019).
  • Over the past 3 years, enVVeno Medical's Current Deferred Revenue (Quarter) stood at $33000.0 in 2018, then changed by 0.0% to $33000.0 in 2019, then changed by 0.0% to $33000.0 in 2020.
  • Its last three reported values are $33000.0 in Q3 2020, $33000.0 for Q1 2020, and $33000.0 during Q4 2019.